The Body’s Endocannabinoid System
As a teenager, Andrew Kerklaan had to see a surgeon. He’d been having numbness and back pain, so he went to the doctor’s office, waited three hours, and was told that nope, sorry, he did not have a back problem and unfortunately the surgeon was really busy and there would be no time for questions. Then he went to a chiropractor. Kerklaan in fact had a stress fracture (something he actually attributes to the paper route he had as a kid). As unpleasant a medical journey as it was, it also brought a pretty big silver lining: Kerklaan became a chiropractor in London and later in his hometown of Montreal, and for the past twenty years he’s been helping people in pain.
Cannabis in Light of the Opioid Crisis
It’s been hotly debated for years: Does cannabis have a legitimate medical use? It’s a Schedule I drug in the United States, meaning the federal government’s official view was—and still is—that marijuana has no legitimate medical purpose. Individual states, however, have recognized the research on marijuana’s clinical benefits for a variety of conditions. Now the first cannabis-derived drug—Epidolex, an oral cannabidiol (CBD) solution used to ease seizures in two rare forms of epilepsy—has been approved by the FDA, and the specific formulation rescheduled to Schedule V (meaning it has accepted medical use and low potential for abuse). This doesn’t affect the scheduling of other CBD products but may open the door for other cannabis-derived drugs in the future.